Mr. Paul Sullivan reports

TRUE LEAF FINALIZES WARRANT REPRICING

True Leaf Medicine International Ltd. warrantholders holding 3,223,227 of the company's warrants expiring on May 29, 2019, and June 12, 2019, have consented to and agreed with the repricing of the exercise price of their warrants from 45 cents per share to 35.5 cents per share.

On Dec. 24, 2018, the company announced that it approved the repricing of these warrants, subject to warrantholders consenting and agreeing to the repricing. The repriced warrants are now subject to an accelerated expiry date in accordance with Canadian Securities Exchange rules whereby the term of the warrants will be reduced to 30 days commencing seven days from the end of the closing market price of the shares exceeding the amended exercise price by 25 per cent for 10 consecutive trading days. Ten per cent of the repriced warrants are held by insiders of the company.

We seek Safe Harbor.